Diagnosis and management of osteomyelitis: Decision analytic and pharmacoeconomic considerations

PharmacoEconomics

Volumn 16, Issue 6, 1999, Pages 627-647

  Tavakoli, Manouche ^a   Davey, Peter ^b   Clift, Benedict A ^c   Davies, Huw T O ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE; METICILLIN; OFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; RIFAMPICIN; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIMICROBIAL THERAPY; ARTHRITIS; CHRONIC OSTEOMYELITIS; FRACTURE; GRAFT INFECTION; HEALTH CARE COST; IMMUNE RESPONSE; INFECTION; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGLIGENCE; OSTEOMYELITIS; PRIORITY JOURNAL; REVIEW;

EID: 0033454723     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916060-00003     Document Type: Review

References (76)

1. Dirschl DR, Almekinders L. Osteomyelitis: common causes and treatment recommendations. Drugs 1993; 45 (1): 29-43
2. Mader JT, Mohan D, Calhoun J. A practical guide to the diagnosis and management of bone and joint infections. Drugs 1997; 54 (2): 253-64
3. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med 1997; 336 (14): 999-1007
4. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 1970; 282: 198-206
5. Sexton DJ, McDonald M. Osteomyelitis: approaching the 1990s. Med J Aust 1990; 153: 91-6
6. Hiramatsu K, Aritaka N, Hanaski H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycine. Lancet 1997; 350: 1670-3
7. Speller DCE, Johnson AP, James D, et al. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323-5
8. Tabaqchali S. Vancomycin-resistant Staphylococcus aureus: apocalypse now? Lancet 1997; 350: 1644-5
9. Davey P, Byrne D. Changes which affect antibiotic prescribing in surgery. In: Murie J, editor. London: Royal College of Surgeons, 1997: 65-72
10. Turnidge J, Grayson ML. Optimum treatment of staphylococcal infections. Drugs 1993; 45 (3): 353-66
11. Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med 1996; 101: 550-61
12. Gentry LO, Rodriguez-Gomez G. Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother 1991; 35: 538-41
13. Mackay WC, Wong JB, Kaplan S, et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA 1995; 273: 712-20
14. Norden C, Gillespie WJ, Nade S. Infections in bones and joints. Boston: Blackwell Scientific Publications, 1994
15. Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants and children: a review of 163 cases. Am J Dis Child 1975; 129: 1273-8
16. Trueta J. The three types of acute haematogenous osteomyelitis: a clinical and vascular study. J Bone Joint Surg Br 1959; 41: 671-80
17. Hawiger JS, Hammond DK, Timmons S, et al. Interaction of human fibrinogen with staphylococci: presence of a binding region on normal and abnormal fibrinogen variants and fibrinogen derivatives. Blood 1978; 51: 799-812
18. Signas C, Raucci G, Jonsson K, et al. Nucleotide sequence of the gene for a fibrinogen-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci U S A 1989; 86: 699-703
19. Rogolsky M. Nonenteric toxins of Staphylococcus aureus. Microbiol Rev 1979; 43 (3): 320-60
20. Patti JM, Jonsson J, Guss B, et al. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem 1992; 267: 4766-72
21. Patti JM, Bremell T, Karjewska-Pietrasik D, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994; 62: 152-61
22. Elliott SY, Kerns FT, Kitchen LW. Vertebral osteomyelitis cases (1987-1991). Infect Dis Clin Pract 1993; 2: 340-4
23. Sapico FL, Montgomerie JZ. Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature. Rev Infect Dis 1979; 1 (5): 754-76
24. O'Brien T, McManus F, MacAuley PH, et al. Acute haematogenous osteomyelitis. J Bone Joint Surg Br 1982; 64B: 450-3
25. Mollan RAB, Piggot J. Acute osteomyelitis in children. J Bone Joint Surg 1977; 59B: 2-7
26. Gentry LO. Osteomyelitis: options for diagnosis and management. J Antimicrob Chemother 1988; 21 Suppl. C: 115-28
27. Gillespie WJ, Mayo KM. The management of acute haematogenous osteomyelitis in the antibiotic era: a study of outcome. J Bone Joint Surg 1981; 63B: 126-31
28. Ingram C, Eron LJ, Goldenberg RI, et al. Antibiotic therapy of osteomyelitis in outpatients. Med Clin North Am 1988; 72: 723-39
29. Parker SE, Davey PG. Pharmacoeconomics of intravenous drug administration. Pharmacoeconomics 1992; 1: 103-15
30. Chapman SW, editor. Osteomyelitis. Boston: Little, Brown & Company, 1986
31. Braun TI, Lorber B, editors. Chronic osteomyelitis. New York: Springer-Verlag, 1988
32. Norden CW. Osteomyelitis. In: Mandell GL, Bennett L, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 922-30
33. Peltola H, Rasanen JA. Quantitative C-reactive protein in relation to erythrocyte sedimentation rate, fever and duration of antimicrobial therapy in bacteraemic diseases of childhood. J Infect 1982; 5: 257-67
34. Wing VW, Jeffery J, Federle MP, et al. Chronic osteomyelitis examined by CT. Radiology 1985; 154: 171-4
35. Naylor PT, Myrvik QN, Gristina A. Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci. Clin Orthop 1990; 261: 126-33
36. Eckardt JJ, Wirganowicz PZ, Mar T. An aggressive surgical approach to the management of chronic osteomyelitis. Clin Orthop 1994; 298: 229-39
37. Bell S. Oral penicillin in the treatment of chronic staphylococcal osteomyelitis. Lancet 1968; 2: 295-7
38. Shaw JL, Bassett CA. The effects of varying oxygen concentrations on osteogenesis and embryonic cartilage in vitro. J Bone Joint Surg 1967; 49A: 73-80
39. Davis JC, Heckman JD, DeLee JC, et al. Chronic non-hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg 1986; 66: 1210-7
40. Morrey BF, Dunn JM, Heimbach RD, et al. Hyperbaric oxygen and chronic osteomyelitis. Clin Orthop 1979; 144: 121-7
41. Scrip yearbook. Richmond: PJB Publications Ltd, 1996
42. Hebert CK, Williams RE, Levy RS, et al. Cost of treating an infected total knee replacement. Clin Orthop 1996; 331: 140-5
43. Drancourt M, Stein A, Argenson JN, et al. Oral rifampin plus ofloxacin for treatment of staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214-8
44. Calhoun JH, Mader JT. Antibiotic beads in the management of surgical infections. Am J Surg 1989; 157: 443-9
45. Duncan CP, Masri BA. The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. J Bone Joint Surg 1994; 76A: 1742-51
46. Hill C, Flamant R, Mazas F, et al. Prophylactic cefazolin versus placebo in total hip replacement: report of a multicentre double-blind randomised trial. Lancet 1981; 1: 795-7
47. Doyon F, Evrard J, Mazas F, et al. Long-term results of prophylactic cefazolin versus placebo in total hip replacement [letter]. Lancet 1987; 1: 860
48. Simmons NA, Ball AP, Cawson RA, et al. Case against antibiotic prophylaxis for dental treatment of patients with joint prostheses [letter]. Lancet 1992; 339: 301
49. Thyne GM, Ferguson JW. Antibiotic prophylaxis during dental treatment in patients with prosthetic joints. J Bone Joint Surg 1991; 73B: 191-4
50. Mader JT, Ortiz M, Calhoun JH. Update on the diagnosis and management of osteomyelitis. Clin Podiatr Med Surg 1996; 13 (4): 701-24
51. Beck RJ, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983; 3 (4): 419-58
52. Sonnenberg FA, Beck RJ. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13 (4): 322-38
53. Davey PG, Parker SE, Malek M. Pharmacoeconomics of antibacterial treatment. Pharmacoeconomics 1992; 1: 409-37
54. Norden CW, Bryant R, Palmer D, et al. Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy. South Med J 1986; 79: 947-51
55. Lieberman JR, Callaway GH, Salvati EA, et al. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop 1994; 301: 205-12
56. Duncan CP, Beauchamp C. A temporary antibiotic-loaded joint replacement system for management of complex infections involving the hip. Orthop Clin North Am 1993; 24 (4): 751-9
57. Hofmann AA, Kane KR, Tkach TK, et al. Treatment of infected total knee arthroplasty using an articulated spacer. Clin Orthop 1995; 321: 45-54
58. Barrack RL, Jennings RW, Wolfe MW, et al. The value of preoperative aspiration before total knee revision. Clin Orthop 1998; 345: 8-12
59. Duff GP, Lachiewicz PF, Kelley SS. Aspiration of the knee joint before revised arthroplasty. Clin Orthop 1998; 331: 132-9
60. Fehring TK, McAlister JA. Frozen histologic section as a guide to sepsis in revision joint arthroplasty. Clin Orthop 1994; 304: 229-37
61. Levine SE, Esterhai JL, Heppenstall RB, et al. Diagnoses and staging: osteomyelitis and prosthetic joint infections. Clin Orthop 1993; 295: 77-86
62. Hanssen AD, Trousdale RT, Osmon DR. Patient outcome with reinfection following reimplantation for the infected total knee arthroplasty. Clin Orthop 1995; 321: 55-67
63. Sanzen L, Carlsson AS, Josefsson G, et al. Revision operations on infected total hip arthroplasties (2-9-year follow-up study). Clin Orthop 1988; 229: 165-72
64. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996; 5 (6): 513-24
65. Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related Staphylococcal infections: a randomized controlled trial. JAMA 1998; 279 (19): 1537-41
66. Lew DP, Waldvogel FA. Quinolones and osteomyelitis: state-of-the-art. Drugs 1995; 49 Suppl. 2: 100-1
67. Dan M, Siegman-Igra Y, Pitlik S, et al. Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis. Antimicrob Agents Chemother 1990; 34 (5): 849-52
68. Dellamonica P, Bernard E, Etesse H, et al. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. Eur J Clin Microbiol Infect Dis 1989; 8 (12): 1024-30
69. Major S, Chuard C, Regamey C. Treatment of osteomyelitis with oral bactericidal antibiotics. Schweiz Med Wochenschr 1996; 126 (4): 124-7
70. Heldman AW, Hartert TV, Ray SC, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996; 101 (1): 68-76
71. Sanchez C, Matamala A, Salavert M, et al. Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection. Enferm Infecc Microbiol Clin 1997; 15 (1): 10-3
72. Crowe M, Ashford K, Ispahani P. Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica. J Med Microbiol 1996; 45 (4): 302-9
73. Rissing JP. Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. Clin Infect Dis 1997; 25 (6): 1327-33
74. Shirtliff ME, Mader JT, Calhoun J. Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. Clin Orthop 1999; 359: 229-36
75. Bayer AS. Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections. Eur J Clin Microbiol Infect Dis 1989; 8 (12): 1102-10
76. Shockett W. Bolam v Friern Hospital Management Committee. All Engl Law Rep 1957; 2: 118-28